{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Leukemia%2C+Myelogenous%2C+Acute&page=86", "query": { "condition": "Leukemia, Myelogenous, Acute", "page": 86 }, "page_size": 10 }, "pagination": { "page": 86, "page_size": 10, "total_count": 2505, "total_pages": 251, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Leukemia%2C+Myelogenous%2C+Acute&page=87&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Leukemia%2C+Myelogenous%2C+Acute&page=85&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-06T14:29:35.346Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01404949", "title": "Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Promyelocytic Leukemia" ], "interventions": [ { "name": "Tretinoin and Arsenic Trioxide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 17, "start_date": "2011-07", "completion_date": "2021-02-01", "has_results": true, "last_update_posted_date": "2021-11-30", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 11, "location_summary": "Los Angeles, California • Evanston, Illinois • Bethesda, Maryland + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01404949" }, { "nct_id": "NCT05038644", "title": "XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukemia", "T Cell Acute Lymphoblastic Leukemia", "T Cell Lymphoblastic Lymphoma" ], "interventions": [ { "name": "XmAb18968 - Dose level 1", "type": "DRUG" }, { "name": "XmAb18968 - Dose level 0 (starting dose)", "type": "DRUG" }, { "name": "XmAb18968 - Dose level 2", "type": "DRUG" }, { "name": "XmAb18968 - Dose level 3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ehab L Atallah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2022-02-02", "completion_date": "2024-11-18", "has_results": false, "last_update_posted_date": "2025-05-08", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Jacksonville, Florida • Tampa, Florida + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT05038644" }, { "nct_id": "NCT00697684", "title": "Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukemia", "Myelodysplastic Syndrome", "Acute Lymphocytic Leukemia", "Relapsed/Refractory Chronic Lymphocytic Leukemia", "Relapsed/Refractory Non Hodgkin's Lymphoma", "Hodgkins Disease", "Relapsed Refractory Multiple Myeloma" ], "interventions": [ { "name": "Antithymocyte Globulin", "type": "DRUG" }, { "name": "Clofarabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 29, "start_date": "2008-06", "completion_date": "2023-11", "has_results": false, "last_update_posted_date": "2023-11-28", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00697684" }, { "nct_id": "NCT00398138", "title": "Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Leukemia", "Lung Cancer", "Malignant Mesothelioma", "Myelodysplastic Syndromes", "Primary Peritoneal Cavity Cancer" ], "interventions": [ { "name": "WT-1 analog peptide vaccine", "type": "BIOLOGICAL" }, { "name": "incomplete Freund's adjuvant", "type": "BIOLOGICAL" }, { "name": "sargramostim", "type": "BIOLOGICAL" }, { "name": "polymerase chain reaction", "type": "GENETIC" }, { "name": "flow cytometry", "type": "OTHER" }, { "name": "immunoenzyme technique", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "GENETIC", "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 22, "start_date": "2006-10", "completion_date": "2009-06", "has_results": true, "last_update_posted_date": "2016-03-02", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00398138" }, { "nct_id": "NCT03836209", "title": "Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia" ], "interventions": [ { "name": "Gilteritinib", "type": "DRUG" }, { "name": "Midostaurin", "type": "DRUG" }, { "name": "Daunorubicin", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "PrECOG, LLC.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 181, "start_date": "2019-12-06", "completion_date": "2026-06-30", "has_results": true, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 44, "location_summary": "Scottsdale, Arizona • Clovis, California • Los Angeles, California + 36 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Clovis", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03836209" }, { "nct_id": "NCT05871008", "title": "Integrated Actionable Aging Assessment for Cancer Patients Pilot", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Hodgkin Lymphoma", "Kidney Cancer", "Leukemia", "Lymphoid Leukemia", "Multiple Myeloma", "Myeloid Leukemia", "Monocytic Leukemia", "Prostate Cancer", "Bladder Cancer" ], "interventions": [ { "name": "Assessment tool IA3-CP with SDoH", "type": "OTHER" }, { "name": "Assessment tool IA3-CP without SDoH", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": "111 Years", "sex": "ALL", "summary": "65 Years to 111 Years" }, "enrollment_count": 35, "start_date": "2024-03-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05871008" }, { "nct_id": "NCT05974150", "title": "Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Lung Cancer", "Multiple Myeloma", "Ovarian Cancer", "Acute Myelogenous Leukemia" ], "interventions": [ { "name": "Web based survey", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Carevive Systems, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2023-07-19", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-10-30", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 7, "location_summary": "New Haven, Connecticut • Evanston, Illinois • Chapel Hill, North Carolina + 4 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Evanston", "state": "Illinois" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05974150" }, { "nct_id": "NCT03844815", "title": "Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukemia" ], "interventions": [ { "name": "Decitabine", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2019-11-18", "completion_date": "2027-12-10", "has_results": false, "last_update_posted_date": "2026-03-04", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03844815" }, { "nct_id": "NCT00125840", "title": "Clofarabine in Adult Patients With Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumors", "Leukemia, Lymphocytic, Acute, Pediatric", "Leukemia, Lymphocytic, Acute, Adult", "Leukemia, Myelocytic, Acute, Pediatric", "Leukemia, Myelocytic, Acute, Adult", "Myelodysplastic Syndromes, Adult" ], "interventions": [ { "name": "clofarabine (IV formulation)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2002-08", "completion_date": "2007-08", "has_results": false, "last_update_posted_date": "2014-02-05", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 2, "location_summary": "Dallas, Texas • Tyler, Texas", "locations": [ { "city": "Dallas", "state": "Texas" }, { "city": "Tyler", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00125840" }, { "nct_id": "NCT00897182", "title": "Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Leukemia" ], "interventions": [ { "name": "microarray analysis", "type": "GENETIC" }, { "name": "polymerase chain reaction", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 96, "start_date": "2008-05", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2016-07-04", "last_synced_at": "2026-11-06T14:29:35.346Z", "location_count": 2, "location_summary": "Fort Wayne, Indiana • Goldsboro, North Carolina", "locations": [ { "city": "Fort Wayne", "state": "Indiana" }, { "city": "Goldsboro", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00897182" } ] }